Credit Suisse’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,102
Closed -$2.57K 3247
2022
Q4
$2.57K Buy
1,102
+483
+78% +$1.13K ﹤0.01% 3526
2022
Q3
$1K Buy
619
+618
+61,800% +$998 ﹤0.01% 3774
2022
Q2
$0 Buy
+1
New ﹤0.01% 3858
2022
Q1
Sell
-11,271
Closed -$44K 3540
2021
Q4
$44K Buy
+11,271
New +$44K ﹤0.01% 3567
2021
Q3
Sell
-86,771
Closed -$262K 3501
2021
Q2
$262K Sell
86,771
-18,395
-17% -$55.5K ﹤0.01% 3332
2021
Q1
$350K Buy
105,166
+86,015
+449% +$286K ﹤0.01% 3111
2020
Q4
$68K Buy
+19,151
New +$68K ﹤0.01% 3360
2020
Q2
Sell
-216,708
Closed -$219K 3267
2020
Q1
$219K Buy
216,708
+71,498
+49% +$72.3K ﹤0.01% 2992
2019
Q4
$403K Buy
+145,210
New +$403K ﹤0.01% 3024
2018
Q3
Sell
-11,436
Closed -$84K 3277
2018
Q2
$84K Buy
+11,436
New +$84K ﹤0.01% 3389
2017
Q4
Sell
-176,091
Closed -$1.09M 3457
2017
Q3
$1.09M Buy
176,091
+91
+0.1% +$564 ﹤0.01% 2584
2017
Q2
$634K Sell
176,000
-1
-0% -$4 ﹤0.01% 2619
2017
Q1
$572K Sell
176,001
-79
-0% -$257 ﹤0.01% 2842
2016
Q4
$431K Sell
176,080
-1,180
-0.7% -$2.89K ﹤0.01% 3162
2016
Q3
$610K Buy
177,260
+990
+0.6% +$3.41K ﹤0.01% 2987
2016
Q2
$613K Buy
176,270
+120
+0.1% +$417 ﹤0.01% 2997
2016
Q1
$727K Sell
176,150
-81
-0% -$334 ﹤0.01% 2686
2015
Q4
$785K Sell
176,231
-5,421
-3% -$24.1K ﹤0.01% 2808
2015
Q3
$1.11M Buy
181,652
+36,470
+25% +$222K ﹤0.01% 2551
2015
Q2
$1.72M Buy
145,182
+63,363
+77% +$751K ﹤0.01% 2441
2015
Q1
$1.43M Buy
+81,819
New +$1.43M ﹤0.01% 2453
2014
Q3
Sell
-33,688
Closed -$440K 4016
2014
Q2
$440K Sell
33,688
-3,716
-10% -$48.5K ﹤0.01% 3487
2014
Q1
$804K Buy
+37,404
New +$804K ﹤0.01% 2970